These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28800526)

  • 41. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid separation and identification of phenolic and diterpenoid constituents from Radix Salvia miltiorrhizae by high-performance liquid chromatography diode-array detection, electrospray ionization time-of-flight mass spectrometry and electrospray ionization quadrupole ion trap mass spectrometry.
    Zhu Z; Zhang H; Zhao L; Dong X; Li X; Chai Y; Zhang G
    Rapid Commun Mass Spectrom; 2007; 21(12):1855-65. PubMed ID: 17510941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel liquid chromatography/tandem mass spectrometry method for the quantification of glycine as biomarker in brain microdialysis and cerebrospinal fluid samples within 5min.
    Voehringer P; Fuertig R; Ferger B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():92-7. PubMed ID: 24121745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.
    Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R
    J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Review of ceftaroline fosamil microbiology: integrated FOCUS studies.
    Critchley IA; Eckburg PB; Jandourek A; Biek D; Friedland HD; Thye DA
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii45-51. PubMed ID: 21482569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials.
    Taboada M; Melnick D; Iaconis JP; Sun F; Zhong NS; File TM; Llorens L; Friedland HD; Wilson D
    J Antimicrob Chemother; 2016 Apr; 71(4):862-70. PubMed ID: 26702925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous determination of chromones and coumarins in Radix Saposhnikoviae by high performance liquid chromatography with diode array and tandem mass detectors.
    Kim MK; Yang DH; Jung M; Jung EH; Eom HY; Suh JH; Min JW; Kim U; Min H; Kim J; Han SB
    J Chromatogr A; 2011 Sep; 1218(37):6319-30. PubMed ID: 21807369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of aminoglycoside residues in milk and muscle based on a simple and fast extraction procedure followed by liquid chromatography coupled to tandem mass spectrometry and time of flight mass spectrometry.
    Arsand JB; Jank L; Martins MT; Hoff RB; Barreto F; Pizzolato TM; Sirtori C
    Talanta; 2016 Jul; 154():38-45. PubMed ID: 27154646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity.
    Drusano GL
    J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv33-9. PubMed ID: 21115453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of ceftaroline fosamil for bacteremia associated with community-acquired bacterial pneumonia.
    Jandourek A; Smith A; Llorens L; Thye DA; Eckburg PB; Friedland HD
    Hosp Pract (1995); 2014 Feb; 42(1):75-8. PubMed ID: 24566599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
    Singh BN; Dedhiya MG; DiNunzio J; Chan P; Kupiec TC; Trissel LA; Laudano JB
    Am J Health Syst Pharm; 2011 Nov; 68(22):2163-9. PubMed ID: 22058102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analyses of macrolide antibiotic residues in eggs, raw milk, and honey using both ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry and high-performance liquid chromatography/tandem mass spectrometry.
    Wang J; Leung D
    Rapid Commun Mass Spectrom; 2007; 21(19):3213-22. PubMed ID: 17768705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infection.
    Korczowski B; Antadze T; Giorgobiani M; Stryjewski ME; Jandourek A; Smith A; O'Neal T; Bradley JS
    Pediatr Infect Dis J; 2016 Aug; 35(8):e239-47. PubMed ID: 27164462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Determination of six cephalosporin residues in milk by QuEChERS-ultra high performance liquid chromatography-tandem mass spectrometry].
    Zhang X; Wang X; Dai C; Chen M
    Se Pu; 2018 Apr; 36(4):345-350. PubMed ID: 30136516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ceftaroline fosamil treatment outcomes compared with standard of care among hospitalized patients with complicated skin and soft tissue infections.
    Karve S; Hackett J; Levinson J; Gibson E; Battersby A
    J Comp Eff Res; 2016 Jul; 5(4):393-405. PubMed ID: 26946948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection.
    Casapao AM; Steed ME; Levine DP; Rybak MJ
    Expert Opin Pharmacother; 2012 Jun; 13(8):1177-86. PubMed ID: 22594846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and validation of an ultra high performance liquid chromatography tandem mass spectrometry method for determination of 10 cephalosporins and desacetylcefapirin in milk.
    Hou XL; Wu YL; Lv Y; Xu XQ; Zhao J; Yang T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():6-11. PubMed ID: 23747425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
    Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
    J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and characterization of stress degradants of lacosamide by LC-MS and ESI-Q-TOF-MS/MS: development and validation of a stability indicating RP-HPLC method.
    Ramisetti NR; Kuntamukkala R; Lakshetti S; Sripadi P
    J Pharm Biomed Anal; 2014 Jul; 95():256-64. PubMed ID: 24699370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.